跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 31,490 条关于
“Polpharma Biologics Group”
全部
31,490
临床试验
19,977
药物
1,108
机构
651
资讯
9,754
去年
Polpharma Biologics and Fresenius Kabi Partner on Vedolizumab Biosimilar for Inflammatory Bowel Disease
去年
Chime Biologics and Polpharma Biologics Form Strategic Partnership to Accelerate Global Biosimilar Development
11个月前
Europe's First Ranibizumab Biosimilar Pre-filled Syringe Launches in France
去年
Formycon's Ranivisio Becomes First Lucentis Biosimilar Approved in Brazil
9个月前
Polpharma Biologics Partners with Libbs Farmacêutica to Bring Autoimmune Biosimilar to Brazilian Market
去年
Stevanato Group Secures €200 Million Financing to Expand Biologics Manufacturing Capacity
2个月前
Samsung Biologics to Acquire PolyPeptide Group in $1.8 Billion Deal, Entering the Booming Peptide CDMO Market
10个月前
Sandoz Launches First FDA-Approved Multiple Sclerosis Biosimilar TYRUKO in US Market
2年前
Pharmacosmos Group Acquires G1 Therapeutics for $405 Million to Expand COSELA Access for Cancer Patients
去年
Psyence Group Expands Psilocybin Clinical Trials for Adjustment Disorder in Palliative Care
第 1 页,共 976 页
上一页
下一页